NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Krista DavisSVP CHIEF HR OFFICER2025-09-121,710$97.71
$167.08kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-09-12400$98.42
$39.37kSell
Antonio R. PeraDirector2025-09-037,292$94.94
$692.30kSell
Matthew J. LeonardDirector2025-08-252,528$90.62
$229.09kSell
Krista DavisSVP CHIEF HR OFFICER2025-08-221,763$91.10
$160.61kSell
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2025-08-2152,988$90.44
$4.79MSell
Antonio R. PeraDirector2025-08-205,421$89.73
$486.43kSell
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2025-08-2047,012$90.27
$4.24MSell
Jeanne ThomaDirector2025-08-1814,675$88.87
$1.30MSell
Matthew J. LeonardDirector2025-08-186,937$88.17
$611.64kSell

1 of 8

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP86.50%18,737,728$1.83BInsider
Robert E. Brown Jr.78.33%16,967,490$1.66BInsider
Ross J. Mangano26.74%5,792,084$565.02MInsider
Blackrock Inc11.91%2,580,537$251.73MInstitution
Tracy Marshbanks10.66%2,308,568$225.20MInsider
Vanguard Group Inc5.90%1,277,354$124.61MInstitution
Millennium Management LLC4.63%1,003,876$97.93MInstitution
Victor A. Morgenstern4.32%936,014$91.31MInsider
Global Alpha Capital Management Ltd3.98%862,090$84.10MInstitution
State Street Corp3.31%716,117$69.86MInstitution

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP29.08%70.92%Net SellingNet Selling
ALVO5.53%0.00%
SUPN46.27%53.73%Net BuyingNet Buying
BHC51.69%48.31%Net BuyingNet Buying
HROW28.63%71.37%Net SellingNet Buying

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 90.97% institutional shareholders, 221.84% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 86.50% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.79B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.